These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6334173)

  • 21. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part III-2. Chronic toxicity in beagle dogs: 13-week-treatment in male dogs.
    Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Kumagai K; Suzuki H; Suzuki M; Sugiyama N
    Jpn J Antibiot; 1984 Jul; 37(7):1377-82. PubMed ID: 6333531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part III-4. Chronic toxicity in beagle dogs: 26-week-treatment in male dogs.
    Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Kumagai K; Suzuki H; Suzuki M; Sugiyama N
    Jpn J Antibiot; 1984 Jul; 37(7):1399-416. PubMed ID: 6333533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part III-3. Chronic toxicity in beagle dogs: 26-week-treatment in female dogs.
    Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Kumagai K; Suzuki H; Suzuki M; Sugiyama N
    Jpn J Antibiot; 1984 Jul; 37(7):1383-98. PubMed ID: 6333532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative toxicity study of rokitamycin and josamycin in rats].
    Miura M; Morino T; Endo H; Shiraiwa K; Matsumoto K; Hayano K
    Jpn J Antibiot; 1987 Mar; 40(3):588-601. PubMed ID: 3613079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tissue distribution of 9, 3"-diacetylmidecamycin in the pregnant rat and in the rat following repeated administration (author's transl)].
    Someya S; Shomura T; Murata S
    Jpn J Antibiot; 1982 Mar; 35(3):761-5. PubMed ID: 6980293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay for metabolites of 9,3"-diacetylmidecamycin, a macrolide antibiotic.
    Shimada N; Ueda T; Yokoshima T; Umemura K; Shomura T
    Antimicrob Agents Chemother; 1982 Dec; 22(6):976-80. PubMed ID: 6984320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
    Kawaharajo K; Sekizawa Y; Inoue M
    J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicological studies on the new veterinary antibiotic turimycin.
    Härtl A; Hoffmann H
    Pol J Pharmacol Pharm; 1980; 32(2):217-24. PubMed ID: 7454626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers].
    Couet W; Girault J; Reigner B; Ingrand I; Bizouard J; Fourtillan JB
    Pathol Biol (Paris); 1989 May; 37(5):428-32. PubMed ID: 2789363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyl derivatives of 16-membered macrolides. I. Synthesis and biological properties of 3"-O-propionylleucomycin A5 (TMS-19-Q).
    Sakakibara H; Okekawa O; Fujiwara T; Otani M; Omura S
    J Antibiot (Tokyo); 1981 Aug; 34(8):1001-10. PubMed ID: 7319915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [General pharmacological studies on a new macrolide antibiotic, miokamycin (MOM). 1. Effects on the central nervous system (author's transl)].
    Shibata U; Yamaki Y; Asaoka H; Sugiyama S; Takeda U; Nishimori T; Kobayashi F; Hori K
    Jpn J Antibiot; 1981 May; 34(5):734-46. PubMed ID: 6974788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Safety evaluation of micronomicin. I. Subacute and chronic toxicity in dogs].
    Hara T; Nishikawa S; Miyazaki H; Ohguro Y
    Jpn J Antibiot; 1983 Jan; 36(1):150-73. PubMed ID: 6842822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of ponsinomycine with repeated ingestion in healthy volunteers].
    Couet W; Reigner BG; Ingrand I; Girault J; Istin B; Bizouard J; Fourtillan JB
    Therapie; 1990; 45(2):105-9. PubMed ID: 2353325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety evaluation of micronomicin V. Subacute toxicity in rats after intravenous injection].
    Hara T; Harada S; Yamamoto M; Kashitani J; Deguchi T
    Jpn J Antibiot; 1983 Nov; 36(11):3208-25. PubMed ID: 6674533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
    Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of food intake on the bioavailability of ponsinomycin administered in a syrup form].
    Fourtillan JB; Couet W; Ingrand I; Reigner B; Bizouard J; Girault J
    Pathol Biol (Paris); 1989 May; 37(5):446-50. PubMed ID: 2789364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Toxicological study of amikacin following intravenous drip infusion. 1. Acute toxicity in rats, rabbits and dogs, and subacute toxicity in rabbits].
    Nakamura K; Akutsu S; Matsumoto H; Samura K; Nakata Y; Asano M; Hirata A; Ishikawa H; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2048-67. PubMed ID: 7154250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery].
    Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y
    Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345
    [No Abstract]   [Full Text] [Related]  

  • 40. Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin.
    Capelli A; Capelli O; Azzolini L; Richeldi L; Prandi E; Velluti G
    Chemioterapia; 1988 Apr; 7(2):89-95. PubMed ID: 3260827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.